Drug Interactions between Lithium Carbonate ER and risperidone
This report displays the potential drug interactions for the following 2 drugs:
- Lithium Carbonate ER (lithium)
- risperidone
Interactions between your drugs
lithium risperiDONE
Applies to: Lithium Carbonate ER (lithium) and risperidone
MONITOR: Coadministration of lithium with neuroleptic agents, particularly haloperidol, has been associated with rare cases of an encephalopathic syndrome characterized by weakness, lethargy, fever, tremors, confusion, extrapyramidal symptoms, leukocytosis, and elevated liver enzymes and blood urea nitrogen. This syndrome may be similar to, or the same as, neuroleptic malignant syndrome. Other, more common central nervous system effects may also be increased, such as dizziness, drowsiness, confusion, difficulty concentrating, and impairment in thinking, judgment, and motor coordination.
MANAGEMENT: Close monitoring for central nervous system adverse effects is recommended when lithium is used with neuroleptic agents. Dosage adjustments or discontinuation of one or both drugs may be necessary if an interaction is suspected.
References (2)
- Swanson CL, Price WA, Mcevoy JP (1995) "Effects of concomitant risperidone and lithium treatment." Am J Psychiatry, 152, p. 1096
- Goldman SA (1996) "FDA medwatch report: lithium and neuroleptics in combination: the spectrum of neurotoxicity." Psychopharmacol Bull, 32, p. 299-309
Drug and food interactions
lithium food
Applies to: Lithium Carbonate ER (lithium)
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References (4)
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
risperiDONE food
Applies to: risperidone
GENERALLY AVOID: Risperidone oral solution is not compatible with either tea or cola. In addition, alcohol may potentiate some of the pharmacologic effects of risperidone. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Risperidone oral solution should not be mixed with tea or cola. It may be taken with water, coffee, orange juice, or lowfat milk. Patients should also be advised to avoid consumption of alcohol.
References (1)
- (2001) "Product Information. Risperdal (risperidone)." Janssen Pharmaceuticals
lithium food
Applies to: Lithium Carbonate ER (lithium)
MONITOR: One study has suggested that caffeine withdrawal may significantly increase blood lithium levels. The mechanism may be involve reversal of a caffeine-induced increase in renal lithium excretion.
MANAGEMENT: When caffeine is eliminated from the diet of lithium-treated patients, caution should be exercised. When caffeine consumption is decreased, close observation for evidence of lithium toxicity and worsening of the psychiatric disorder is recommended. Patients should be advised to notify their physician if they experience symptoms of possible lithium toxicity such as drowsiness, dizziness, weakness, ataxia, tremor, vomiting, diarrhea, thirst, blurry vision, tinnitus, or increased urination.
References (1)
- Mester R, Toren P, Mizrachi I, Wolmer L, Karni N, Weizman A (1995) "Caffeine withdrawal increases lithium blood levels." Biol Psychiatry, 37, p. 348-50
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.